Serum C-Reactive Protein in Children with Liver Disease and Ascites

Authors Information
Article Notes and Dates
To Cite : Kalvandi G, Honar N, Geramizadeh B, Ataollahi M, Rahmani A, et al. Serum C-Reactive Protein in Children with Liver Disease and Ascites, Hepat Mon. 2016 ;16(8):e38973. doi: 10.5812/hepatmon.38973.
Copyright: Copyright © 2016, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Arvaniti V, D'Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010; 139(4): 1246-56[DOI][PubMed]
  • 2. Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R. Severe sepsis in cirrhosis. Hepatology. 2009; 50(6): 2022-33[DOI][PubMed]
  • 3. El-Shabrawi MH, El-Sisi O, Okasha S, Isa M, Elmakarem SA, Eyada I, et al. Diagnosis of spontaneous bacterial peritonitis in infants and children with chronic liver disease: A cohort study. Ital J Pediatr. 2011; 37: 26[DOI][PubMed]
  • 4. Song KH, Jeon JH, Park WB, Park SW, Kim HB, Oh MD, et al. Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study. BMC Infect Dis. 2009; 9: 41[DOI][PubMed]
  • 5. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002; 35(1): 140-8[DOI][PubMed]
  • 6. Wong F, Bernardi M, Balk R, Christman B, Moreau R, Garcia-Tsao G, et al. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut. 2005; 54(5): 718-25[DOI][PubMed]
  • 7. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med. 1999; 340(3): 207-14[DOI][PubMed]
  • 8. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999; 340(6): 448-54[DOI][PubMed]
  • 9. Chinnock B, Afarian H, Minnigan H, Butler J, Hendey GW. Physician clinical impression does not rule out spontaneous bacterial peritonitis in patients undergoing emergency department paracentesis. Ann Emerg Med. 2008; 52(3): 268-73[DOI][PubMed]
  • 10. Runyon BA, McHutchison JG, Antillon MR, Akriviadis EA, Montano AA. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology. 1991; 100(6): 1737-42[PubMed]
  • 11. Koulaouzidis A, El-Ramli R, Gasem J, Saeed AA. Leukocyte esterase reagent strips for spontaneous bacterial peritonitis: what now? Ann Hepatol. 2008; 7(3): 255-6[PubMed]
  • 12. Moosa AA, Quortum HA, Ibrahim MD. Rapid diagnosis of bacterial meningitis with reagent strips. Lancet. 1995; 345(8960): 1290-1[PubMed]
  • 13. Azoulay E, Fartoukh M, Galliot R, Baud F, Simonneau G, Le Gall JR, et al. Rapid diagnosis of infectious pleural effusions by use of reagent strips. Clin Infect Dis. 2000; 31(4): 914-9[DOI][PubMed]
  • 14. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med. 1993; 119(8): 771-8[PubMed]
  • 15. Roumen RM, Redl H, Schlag G, Zilow G, Sandtner W, Koller W, et al. Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. Crit Care Med. 1995; 23(3): 474-80[PubMed]
  • 16. Memis D, Gursoy O, Tasdogan M, Sut N, Kurt I, Ture M, et al. High C-reactive protein and low cholesterol levels are prognostic markers of survival in severe sepsis. J Clin Anesth. 2007; 19(3): 186-91[DOI][PubMed]
  • 17. Thijs LG, Hack CE. Time course of cytokine levels in sepsis. Intensive Care Med. 1995; 21 Suppl 2-63[PubMed]
  • 18. Povoa P, Almeida E, Moreira P, Fernandes A, Mealha R, Aragao A, et al. C-reactive protein as an indicator of sepsis. Intensive Care Med. 1998; 24(10): 1052-6[PubMed]
  • 19. Yentis SM, Soni N, Sheldon J. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med. 1995; 21(7): 602-5[PubMed]
  • 20. Smith RP, Lipworth BJ, Cree IA, Spiers EM, Winter JH. C-reactive protein. A clinical marker in community-acquired pneumonia. Chest. 1995; 108(5): 1288-91[PubMed]
  • 21. Park WB, Lee KD, Lee CS, Jang HC, Kim HB, Lee HS, et al. Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis. Diagn Microbiol Infect Dis. 2005; 51(4): 227-30[DOI][PubMed]
  • 22. Le Moine O, Devière J, Devaster J, Crusiaux A, Durand F, Bernuau J, et al. Interleukin-6: an early marker of bacterial infection in decompensated cirrhosis. J Hepatol. 1994; 20(6): 819-24
  • 23. Foreman MG, Mannino DM, Moss M. Cirrhosis as a risk factor for sepsis and death: analysis of the National Hospital Discharge Survey. Chest. 2003; 124(3): 1016-20[PubMed]
  • 24. Preto-Zamperlini M, Farhat SC, Perondi MB, Pestana AP, Cunha PS, Pugliese RP, et al. Elevated C-reactive protein and spontaneous bacterial peritonitis in children with chronic liver disease and ascites. J Pediatr Gastroenterol Nutr. 2014; 58(1): 96-8[DOI][PubMed]
  • 25. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992; 20(6): 864-74[PubMed]
  • 26. Caruntu FA, Benea L. Spontaneous bacterial peritonitis: pathogenesis, diagnosis, treatment. J Gastrointestin Liver Dis. 2006; 15(1): 51-6[PubMed]
  • 27. Yuan LY, Ke ZQ, Wang M, Li Y. Procalcitonin and C-reactive protein in the diagnosis and prediction of spontaneous bacterial peritonitis associated with chronic severe hepatitis B. Ann Lab Med. 2013; 33(6): 449-54[DOI][PubMed]
  • 28. Viallon A, Zeni F, Pouzet V, Lambert C, Quenet S, Aubert G, et al. Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines. Intensive Care Med. 2000; 26(8): 1082-8[PubMed]
  • 29. Kasztelan-Szczerbinska B, Slomka M, Celinski K, Serwacki M, Szczerbinski M, Cichoz-Lach H. Prevalence of spontaneous bacterial peritonitis in asymptomatic inpatients with decompensated liver cirrhosis - a pilot study. Adv Med Sci. 2011; 56(1): 13-7[DOI][PubMed]
  • 30. Vieira SM, Matte U, Kieling CO, Barth AL, Ferreira CT, Souza AF, et al. Infected and noninfected ascites in pediatric patients. J Pediatr Gastroenterol Nutr. 2005; 40(3): 289-94[PubMed]
  • 31. Kwon JH, Jang JW, Kim YW, Lee SW, Nam SW, Jaegal D, et al. The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis. BMC Gastroenterol. 2015; 15: 146[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check